Comparison

MK-677 vs Ipamorelin

Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research

MK-677

Also: Ibutamoren, Nutrobal

Clinical Trials

An orally active growth hormone secretagogue that mimics ghrelin. Not a peptide technically, but frequently discussed alongside GH peptides due to similar effects.

Growth HormoneHuman Trials
Ipamorelin

Also: IPAM, NNC 26-0161

Clinical Trials

A selective growth hormone secretagogue that stimulates GH release without significantly affecting cortisol or prolactin. Considered one of the safest GHRPs.

Growth HormoneHuman Trials

Key Comparison Insights

  • Both peptides belong to the Growth Hormone category, suggesting similar primary applications.

Detailed Comparison

AttributeMK-677Ipamorelin
CategoryGrowth HormoneGrowth Hormone
FDA StatusNot FDA ApprovedNot FDA Approved
Clinical Status
Pre
I
II
III
IV
FDA
Pre
I
II
III
IV
FDA
Mechanism of ActionMK-677 binds to ghrelin receptors (GHSR) in the brain, stimulating sustained GH release and increasing IGF-1 levels. Unlike injectable GHRPs, it's orally bioavailable and has a long half-life providing 24-hour GH elevation.Ipamorelin binds to ghrelin receptors (GHSR) in the pituitary gland, triggering growth hormone release. Unlike other GHRPs, it does not stimulate significant ACTH, cortisol, prolactin, or aldosterone release, making it highly selective for GH.
Common Dosing
10-25 mg daily
Once daily, often before bed
200-300 mcg 2-3x daily
2-3x daily
AdministrationOralSubcutaneous injection
Typical Duration8-12 weeks or longer8-12 weeks typical
Best Time to TakeBefore bedBefore bed or morning (fasted)
Possible Side Effects
May vary by individual
  • Increased appetite and hunger
  • Weight gain
  • Water retention
  • Insulin resistance
  • Elevated blood glucose
  • +3 more
  • Generally well-tolerated
  • Injection site reactions
  • Headache
  • Nausea
  • Increased appetite
  • +4 more
Research SummaryStudies show significant increases in GH and IGF-1 levels, improved sleep quality, and increased lean body mass. Research in elderly shows reversal of diet-induced nitrogen wasting. Long-term studies demonstrate sustained efficacy.Clinical studies show dose-dependent GH release with minimal side effects. Research demonstrates improved bone density in postmenopausal women and potential benefits for muscle mass and recovery. Has been studied for post-surgical recovery.

Frequently Asked Questions: MK-677 vs Ipamorelin

What is the difference between MK-677 and Ipamorelin?

MK-677 is a growth hormone peptide that an orally active growth hormone secretagogue that mimics ghrelin. not a peptide technically, but frequently discussed alongside gh peptides due to similar effects. Ipamorelin is a growth hormone peptide that a selective growth hormone secretagogue that stimulates gh release without significantly affecting cortisol or prolactin. considered one of the safest ghrps. The main differences lie in their mechanisms of action and clinical applications.

Which is better, MK-677 or Ipamorelin?

Neither is universally "better" - the choice depends on your specific goals. MK-677 is typically used for growth hormone purposes, while Ipamorelin is used for growth hormone. Always consult with a healthcare provider to determine which may be appropriate for your situation.

Can MK-677 and Ipamorelin be used together?

Some peptide protocols combine multiple compounds for synergistic effects. However, using MK-677 and Ipamorelin together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.

Related Comparisons

View Full Peptide Profiles

Educational Information Only

This comparison of MK-677 and Ipamorelin is for educational purposes only. Neither this comparison nor any information on this site constitutes medical advice. Always consult with qualified healthcare providers before making decisions about peptides or other substances.